Literature DB >> 3300284

Nonleukemic granulocytic sarcoma of the heart: a report of a fatal case.

K Foucar, E Foucar, C Willman, A Horvath, R L Gerety.   

Abstract

We report the clinical and pathological features of a cardiac fatality caused by granulocytic sarcoma in a young adult man with no evidence of leukemia involving bone marrow or peripheral blood. At autopsy, walls of the four cardiac chambers were massively infiltrated by tumor, resulting in a cardiac weight of almost three times normal. Routine cytochemical stains plus immunoperoxidase staining for OKM1 confirmed the diagnosis. Although subclinical cardiac infiltrates are commonly detected at autopsy in patients with acute nonlymphoblastic leukemia (ANLL), massive cardiac granulocytic sarcoma in the absence of bone marrow disease has not been previously described. Cytochemical and immunological methods of diagnosing granulocytic sarcoma in fixed tissues are reviewed.

Entities:  

Mesh:

Year:  1987        PMID: 3300284     DOI: 10.1002/ajh.2830250312

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  4 in total

1.  Myeloid sarcoma of the heart.

Authors:  Raya Mawad; David Wu; Janis L Abkowitz; Roland B Walter
Journal:  Leuk Lymphoma       Date:  2012-05-21

2.  Therapy-related myelodysplastic syndrome presenting as fulminant heart failure secondary to myeloid sarcoma.

Authors:  Kristina A Matkowskyj; William R Wiseman; Jason C Robin; John P Norvell; Jyothy Puthumana; Beverly Nelson; Loann Peterson; Thomas J McGarry; Warren G Tourtellotte
Journal:  J Hematop       Date:  2010-05-05       Impact factor: 0.196

Review 3.  Cardiac Myeloid Sarcoma: Review of Literature.

Authors:  Archana Gautam; Ghazal Kooshk Jalali; Kamal Kant Sahu; Prateek Deo; Sikander Ailawadhi
Journal:  J Clin Diagn Res       Date:  2017-03-01

4.  Cardiac granulocytic sarcoma diagnosed by intracardiac echocardiography-guided biopsy.

Authors:  Mirta Koželj; Darko Zorman; Blaž Mrevlje; Peter Černelč; Samo Zver
Journal:  Int J Hematol       Date:  2008-05-24       Impact factor: 2.490

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.